UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)*
Cytori Therapeutics, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
23283K105
- --------------------------------------------------------------------------------
(CUSIP Number)
September 25, 2009
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 23283K105
- --------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
Seaside 88, LP
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
1,895,800
NUMBER OF
-------------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 0
OWNED BY
-------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 1,895,800
PERSON
-------------------------------------------------------------
WITH: 8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,895,800
- --------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
|-|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
CUSIP No. 23283K105
- --------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
Seaside 88 Advisors, LLC
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
1,895,800
NUMBER OF
------------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 0
OWNED BY
------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 1,895,800
PERSON
------------------------------------------------------------
WITH: 8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,895,800
- --------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
|_|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
CUSIP No. 23283K105
- --------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
William J. Ritger
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0
NUMBER OF
------------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 1,895,800
OWNED BY
------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
PERSON
------------------------------------------------------------
WITH: 8 SHARED DISPOSITIVE POWER
1,895,800
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,895,800
- --------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
|_|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
CUSIP No. 23283K105
- --------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
Denis M. O'Donnell
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
0
NUMBER OF
-------------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY 1,895,800
OWNED BY
-------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
PERSON
-------------------------------------------------------------
WITH: 8 SHARED DISPOSITIVE POWER
1,895,800
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,895,800
- --------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
|_|
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
SCHEDULE 13G
- ------------
Item 1(a) Name of Issuer.
Cytori Therapeutics, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices.
3020 Callan Road, San Diego, CA 92121
Item 2(a) Name of Person Filing.
Seaside 88, LP
Seaside 88 Advisors, LLC
William J. Ritger
Denis M. O'Donnell
Item 2(b) Address of Principal Business Office.
The principal business address of the reporting persons is 750
Ocean Royale Way, Suite 805, North Palm Beach, FL 33408
Item 2(c) Place of Organization.
Reference is made to Item 4 of pages 2-5 of this Schedule 13G
which Items are incorporated herein by reference
Item 2(d) Title of Class of Securities.
Common Stock, $0.001 par value per share
Item 2(e) CUSIP Number.
23283K105
Item 3 If this statement is filed pursuant to ss.ss.240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a) Broker or dealer registered under section 15 of the
Act (15 U.S.C. 78o).
(b) Bank as defined in section 3(a)(6) of the Act (15
U.S.C. 78c).
(c) Insurance company as defined in section 3(a)(19) of
the Act (15 U.S.C. 78c).
(d) Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C 80a-8).
(e) An investment adviser in accordance with
ss.240.13d-1(b)(1)(ii)(E);
(f) An employee benefit plan or endowment fund in
accordance with ss.240.13d-1(b)(1)(ii)(F);
(g) A parent holding company or control person in
accordance with ss. 240.13d-1(b)(1)(ii)(G);
(h) A savings associations as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) A church plan that is excluded from the definition of
an investment company under section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) Group, in accordance with ss.240.13d-1(b)(1)(ii)(J).
Item 4 Ownership.
Reference is hereby made to Items 5-9 and 11 of pages 2-5 of
this Schedule 13G, which Items are incorporated by reference herein.
The securities to which this Schedule relates (the
"Securities") are owned by Seaside 88, LP, a Florida limited partnership
("Seaside"), for which Seaside 88 Advisors, LLC serves as general partner.
William J. Ritger and Denis M. O'Donnell, as managing members of the general
partner of Seaside, may therefore be deemed to beneficially own the Securities
owned by Seaside for the purposes of Rule 13d-3 of the Securities Exchange Act
of 1934, as amended (the "Act"), insofar as they may be deemed to have the power
to direct the voting or disposition of those Securities.
Neither the filing of this Schedule nor any of its contents
shall be deemed to constitute an admission that any of Seaside 88 Advisors, LLC,
Mr. Ritger or Dr. O'Donnell is, for any other purpose, the beneficial owner of
any of the Securities, and each of Seaside 88 Advisors, LLC, Mr. Ritger and Dr.
O'Donnell disclaims beneficial ownership as to the Securities, except to the
extent of his or its pecuniary interests therein.
Under the definition of "beneficial ownership" in Rule 13d-3
under the Act, it is also possible that the members of Seaside might be deemed
the "beneficial owners" of some or all of the Securities insofar as they may be
deemed to share the power to direct the voting or disposition of the Securities.
Neither the filing of this Schedule nor any of its contents shall be deemed to
constitute an admission that any of such individuals is, for any purpose, the
beneficial owner of any of the Securities, and such beneficial ownership is
expressly disclaimed.
The calculation of the number of shares owned includes shares
currently owned by Seaside together with shares that Seaside has the right to
acquire within 60 days of the date hereof.
Item 5 Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6 Ownership of More Than Five Percent on Behalf of Another
Person.
Not applicable.
Item 7 Identification and Classification of the Subsidiary which
Acquired the Security Being Reported On by the Parent Holding
Company.
Not applicable.
Item 8 Identification and Classification of Members of the Group.
Not applicable.
Item 9 Notice of Dissolution of Group.
Not applicable.
Item 10 Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Date: September 25, 2009 SEASIDE 88, LP
By: SEASIDE 88 ADVISORS, LLC
By: /s/ William J. Ritger
---------------------------
William J. Ritger, Manager
SEASIDE 88 ADVISORS, LLC
By: /s/ William J. Ritger
---------------------------
William J. Ritger, Manager
WILLIAM J. RITGER
/s/ William J. Ritger
----------------------------------------
William J. Ritger
DENIS M. O'DONNELL
/s/ Denis M. O'Donnell
----------------------------------------
Denis M. O'Donnell
EXHIBIT INDEX
-------------
Exhibit A Joint Filing Undertaking Page 10
EXHIBIT A
JOINT FILING UNDERTAKING
The undersigned, being authorized thereunto, hereby execute this
agreement as an exhibit to this Schedule 13G to evidence the agreement of the
below-named parties, in accordance with rules promulgated pursuant to the
Securities Exchange Act of 1934, to file this Schedule, as it may be amended,
jointly on behalf of each of such parties.
Dated: September 25, 2009 SEASIDE 88, LP
By: SEASIDE 88 ADVISORS, LLC
By: /s/ William J. Ritger
---------------------------
William J. Ritger, Manager
SEASIDE 88 ADVISORS, LLC
By: /s/ William J. Ritger
---------------------------
William J. Ritger, Manager
WILLIAM J. RITGER
/s/ William J. Ritger
----------------------------------------
William J. Ritger
DENIS M. O'DONNELL
/s/ Denis M. O'Donnell
----------------------------------------
Denis M. O'Donnell